CIK 0001477449 · Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043705970
- Phone
- 2036352002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-25 | Bischoff Christopher Director | Option exercise | +713 | 3,693 | ||
| 2020-11-25 | Bischoff Christopher Director | Option exercise · Restricted Stock Units | −713 | 1,428 | ||
| 2020-11-25 | Daniel Karen L Director | Option exercise | +7,173 | 21,105 | ||
| 2020-11-25 | Daniel Karen L Director | Option exercise · Restricted Stock Units | −6,460 | 19,382 | ||
| 2020-11-25 | Daniel Karen L Director | Option exercise · Restricted Stock Units | −713 | 1,428 | ||
| 2020-11-25 | Fenwick Sandra L Director | Option exercise | +7,173 | 35,535 | ||
| 2020-11-25 | Fenwick Sandra L Director | Option exercise · Restricted Stock Units | −6,460 | 12,921 | ||
| 2020-11-25 | Fenwick Sandra L Director | Option exercise · Restricted Stock Units | −713 | 1,428 | ||
| 2020-11-19 | TULLMAN GLEN Director | Grant or award · Restricted Stock Units | +1,308 | 1,308 | ||
| 2020-11-19 | Fenwick Sandra L Director | Grant or award · Restricted Stock Units | +1,308 | 1,308 | ||
| 2020-11-19 | Daniel Karen L Director | Grant or award · Restricted Stock Units | +1,308 | 1,308 | ||
| 2020-11-19 | Bischoff Christopher Director | Grant or award · Restricted Stock Units | +1,308 | 1,308 | ||
| 2020-11-10 | Trencher Daniel SVP Corporate Strategy | Option exercise | +3,000 | $22.30 | $67K | 11,413 |
| 2020-11-10 | Trencher Daniel SVP Corporate Strategy | Sale | −3,000 | $180.17 | $541K | 8,413 |
| 2020-11-10 | Trencher Daniel SVP Corporate Strategy | Option exercise · Employee Stock Option (right to buy) | −3,000 | 52,414 | ||
| 2020-11-04 | Verstraete Stephany Chief Marketing Officer | Option exercise | +2,000 | $22.30 | $45K | 15,276 |
| 2020-11-04 | Verstraete Stephany Chief Marketing Officer | Sale | −2,000 | $204.00 | $408K | 13,276 |
| 2020-11-04 | Verstraete Stephany Chief Marketing Officer | Option exercise · Employee Stock Option (right to buy) | −2,000 | 32,600 | ||
| 2020-11-04 | GOREVIC JASON N Chief Executive Officer | Sale | −5,000 | $200.27 | $1.0M | 637,593 |
| 2020-11-04 | Turitz Andrew SVP - Business Development | Option exercise | +1,389 | $22.30 | $31K | 5,404 |
Page 86 of 93 · 1,848 trades